COMPOUND AND ITS COMPLEX WITH RADIONUCLIDE Lu FOR THERANOSTICS OF TUMORS EXPRESSING ON HER2 RECEPTORS Russian patent published in 2024 - IPC C07K14/315 C07K14/76 A61K51/08 A61K103/30 A61P35/00 

Abstract RU 2826247 C1

FIELD: organic chemistry; medical chemistry; oncology.

SUBSTANCE: invention relates to the field of radiopharmaceuticals intended for use as theranostic agents for diagnostics and therapy of tumors expressing on HER2 receptors. Disclosed is a compound for producing a complex with a radionuclide label for theranostics of tumors with hyperexpression of epidermal growth factor type 2 (HER2) of general formula ADAPT6-(SSSG)3-ABD035-GSSC-DOTAGA and a complex comprising a compound according to claim 1 with radionuclide mark, which is 177Lu radionuclide.

EFFECT: wider range of theranostic agents for selective targeting and penetration into pathogenic tumor tissues, with optimal characteristics for targeted radionuclide therapy of tumors with hyperexpression of epidermal growth factor type 2 (HER2).

2 cl, 2 ex

Similar patents RU2826247C1

Title Year Author Number
METHOD FOR PREDICTING THE STATUS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR HER2/NEU IN THE MAIN TUMOR NODE IN BREAST CANCER PATIENTS 2021
  • Bragina Olga Dmitrievna
  • Chernov Vladimir Ivanovich
  • Tolmachev Vladimir Maksimilianovich
  • Tashireva Lyubov Aleksandrovna
  • Garbukov Evgenij Yurevich
  • Vorobeva Anzhelika Grigorevna
  • Orlova Anna Markovna
  • Zelchan Roman Vladimirovich
  • Medvedeva Anna Aleksandrovna
  • Lukina Natalya Aleksandrovna
  • Golberg Viktor Evgenevich
RU2762317C1
METHOD FOR PREDICTION OF HER2/NEU EPIDERMAL GROWTH FACTOR RECEPTOR STATUS IN MAIN TUMOR NODE IN BREAST CANCER PATIENTS 2022
  • Bragina Olga Dmitrievna
  • Chernov Vladimir Ivanovich
  • Tolmachev Vladimir Maksimilianovich
  • Deev Sergej Mikhajlovich
  • Tashireva Lyubov Aleksandrovna
  • Zelchan Roman Vladimirovich
  • Medvedeva Anna Aleksandrovna
RU2779751C1
METHOD OF PREDICTING THE STATUS OF EPIDERMAL GROWTH FACTOR RECEPTOR HER2/NEU IN METASTATIC AXILLARY LYMPH NODES IN PATIENTS WITH BREAST CANCER 2023
  • Bragina Olga Dmitrievna
  • Tashireva Lyubov Aleksandrovna
  • Chernov Vladimir Ivanovich
  • Zelchan Roman Vladimirovich
  • Medvedeva Anna Aleksandrovna
  • Tolmachev Vladimir Maksimilianovich
  • Garbukov Evgenij Yurevich
  • Vostrikova Mariya Aleksandrovna
  • Voronina Anna Sergeevna
RU2803857C1
PSMA-TARGET COMPOUND AND ITS COMPLEX WITH RADIONUCLIDES FOR THERANOSTICS OF TUMOR EXPRESSING PSMA 2022
  • Tolmachev Vladimir Maksimilianovich
  • Orlova Anna Markovna
  • Seitova Kamila
  • Bodenko Vitalina Vasilevna
  • Fanny Lundmark
  • Ayman Abouzayed
  • Ulrika Rosenstrem
RU2803734C1
METHOD OF BREAST CANCER DIAGNOSTICS WITH HER2/NEU HYPEREXPRESSION 2022
  • Bragina Olga Dmitrievna
  • Chernov Vladimir Ivanovich
  • Tolmachev Vladimir Maksimilianovich
  • Deev Sergej Mikhajlovich
  • Shulga Aleksej Anatolevich
  • Konovalova Elena Valerevna
  • Zelchan Roman Vladimirovich
  • Medvedeva Anna Aleksandrovna
  • Garbukov Evgenij Yurevich
RU2800818C1
METHOD FOR PREDICTION OF EPIDERMAL GROWTH FACTOR RECEPTOR STATUS HER2/NEU IN PRIMARY TUMOUR IN PATIENTS WITH BREAST CANCER 2021
  • Bragina Olga Dmitrievna
  • Chernov Vladimir Ivanovich
  • Zelchan Roman Vladimirovich
  • Medvedeva Anna Aleksandrovna
  • Tolmachev Vladimir Maksimilianovich
  • Deev Sergej Mikhajlovich
  • Larkina Mariya Sergeevna
  • Stasyuk Elena Sergeevna
  • Tashireva Lyubov Aleksandrovna
RU2766248C1
METHOD FOR PREDICTING STATUS OF EPIDERMAL GROWTH FACTOR HER2/NEU IN METASTATIC LYMPH NODES IN BREAST CANCER PATIENTS 2021
  • Bragina Olga Dmitrievna
  • Chernov Vladimir Ivanovich
  • Zelchan Roman Vladimirovich
  • Medvedeva Anna Aleksandrovna
  • Tolmachev Vladimir Maksimilianovich
  • Deev Sergej Mikhajlovich
  • Larkina Mariya Sergeevna
  • Stasyuk Elena Sergeevna
  • Tashireva Lyubov Aleksandrovna
RU2757960C1
METHOD FOR RADIONUCLIDE DIAGNOSING OPERABLE BREAST CANCER WITH OVEREXPRESSION OF HER2/NEU 2019
  • Bragina Olga Dmitrievna
  • Chernov Vladimir Ivanovich
  • Zelchan Roman Vladimirovich
  • Medvedeva Anna Aleksandrovna
  • Sinilkin Ivan Gennadevich
  • Tolmachev Vladimir Maksimilianovich
  • Vorobeva Anzhelika Grigorevna
  • Deev Sergej Mikhajlovich
  • Proshkina Galina Mikhajlovna
  • Shulga Aleksej Anatolevich
  • Larkina Mariya Sergeevna
  • Tarabanovskaya Natalya Anatolevna
  • Kazantseva Polina Vadimovna
  • Doroshenko Artem Vasilevich
  • Slonimskaya Elena Mikhajlovna
  • Chojnzonov Evgenij Lkhamatsyrenovich
RU2702294C1
METHOD FOR RADIONUCLIDEAN DIAGNOSTICS OF SECONDARY EDEMATOUS-INFILTRATIVE FORM OF BREAST CANCER WITH OVEREXPRESSION OF HER2/NEU USING RECOMBINANT ADDRESS MOLECULES DARPIN9_29 2019
  • Bragina Olga Dmitrievna
  • Chernov Vladimir Ivanovich
  • Zelchan Roman Vladimirovich
  • Medvedeva Anna Aleksandrovna
  • Sinilkin Ivan Gennadevich
  • Tolmachev Vladimir Maksimilianovich
  • Vorobeva Anzhelika Grigorevna
  • Deev Sergej Mikhajlovich
  • Proshkina Galina Mikhajlovna
  • Shulga Aleksej Anatolevich
  • Larkina Mariya Sergeevna
  • Dudnikova Ekaterina Aleksandrovna
  • Goldberg Viktor Evgenevich
  • Chojnzonov Evgenij Lkhamatsyrenovich
RU2700109C1
METHOD FOR EVALUATING NEOADJUVANT SYSTEMIC THERAPY OF BREAST CANCER WITH HER2/NEU OVEREXPRESSION 2020
  • Bragina Olga Dmitrievna
  • Chernov Vladimir Ivanovich
  • Zelchan Roman Vladimirovich
  • Medvedeva Anna Aleksandrovna
  • Deev Sergei Mikhailovich
  • Tolmachev Vladimir Maksimilianovich
  • Vorobeva Anzhelika Grigorevna
  • Orlova Anna Markovna
RU2737996C1

RU 2 826 247 C1

Authors

Tolmachev Vladimir Maksimilianovich

Iusubov Mekhman Suleiman Ogly

Chernov Vladimir Ivanovich

Deev Sergei Mikhailovich

Dates

2024-09-06Published

2023-11-14Filed